|
Symbiotec Pharmalab Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
6928.42 Cr.
|
P/BV
|
6.02
|
Book Value (Rs.)
|
178.98
|
|
52 Week High/Low (Rs.)
|
1180/934
|
FV/ML
|
2/1
|
P/E(X)
|
63.05
|
|
Bookclosure
|
|
EPS (Rs.)
|
17.10
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | 19.10 | 17.39 | 18.00 |
| Diluted EPS (Rs.) | 19.10 | 17.36 | 18.00 |
| Cash EPS (Rs.) | 26.01 | 25.61 | 25.65 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 183.27 | 149.03 | 130.77 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 183.27 | 149.03 | 130.77 |
| Revenue From Operations / Share (Rs.) | 138.54 | 137.45 | 130.99 |
| PBDIT / Share (Rs.) | 38.41 | 37.72 | 32.63 |
| PBIT / Share (Rs.) | 29.92 | 29.84 | 25.53 |
| PBT / Share (Rs.) | 24.45 | 26.91 | 24.20 |
| Net Profit / Share (Rs.) | 17.52 | 17.73 | 18.55 |
| NP After MI And SOA / Share (Rs.) | 17.52 | 17.70 | 18.32 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | 27.72 | 27.44 | 24.90 |
| PBIT Margin (%) | 21.59 | 21.71 | 19.48 |
| PBT Margin (%) | 17.64 | 19.57 | 18.47 |
| Net Profit Margin (%) | 12.64 | 12.89 | 14.16 |
| NP After MI And SOA Margin (%) | 12.64 | 12.87 | 13.98 |
| Return on Networth / Equity (%) | 9.55 | 11.87 | 14.00 |
| Return on Capital Employeed (%) | 14.97 | 14.73 | 14.79 |
| Return On Assets (%) | 6.17 | 6.12 | 7.73 |
| Long Term Debt / Equity (X) | 0.05 | 0.31 | 0.27 |
| Total Debt / Equity (X) | 0.33 | 0.66 | 0.34 |
| Asset Turnover Ratio (%) | 0.51 | 0.52 | 0.00 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 0.92 | 1.04 | 1.45 |
| Quick Ratio (X) | 0.47 | 0.48 | 0.49 |
| Inventory Turnover Ratio (X) | 3.49 | 2.52 | 0.00 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | 9.51 | 12.86 | 24.66 |
| Interest Coverage Ratio (Post Tax) (%) | 5.69 | 7.05 | 15.02 |